169 related articles for article (PubMed ID: 37881491)
1. TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype
Singh SK; Wang Y; Habib A; Priyadarshini M; Kodavali CV; Chen A; Ma W; Wang J; Hameed NUF; Hu B; Fuller GN; Kulich SM; Amankulor N; Colen RR; Edwards LA; Zinn PO
Front Oncol; 2023; 13():1279806. PubMed ID: 37881491
[TBL] [Abstract][Full Text] [Related]
2. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma Model Using Human Cerebral Organoids.
Ogawa J; Pao GM; Shokhirev MN; Verma IM
Cell Rep; 2018 Apr; 23(4):1220-1229. PubMed ID: 29694897
[TBL] [Abstract][Full Text] [Related]
4. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP
Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951
[TBL] [Abstract][Full Text] [Related]
6. CEREBRAL ORGANOIDS AS A MODEL FOR GLIOBLASTOMA MULTIFORME.
Silvia N; Dai G
Curr Opin Biomed Eng; 2020 Mar; 13():152-159. PubMed ID: 32355905
[TBL] [Abstract][Full Text] [Related]
7. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
8. Development of glioblastoma organoids and their applications in personalized therapy.
Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
[TBL] [Abstract][Full Text] [Related]
9. Murine cell line model of proneural glioma for evaluation of anti-tumor therapies.
Sonabend AM; Yun J; Lei L; Leung R; Soderquist C; Crisman C; Gill BJ; Carminucci A; Sisti J; Castelli M; Sims PA; Bruce JN; Canoll P
J Neurooncol; 2013 May; 112(3):375-82. PubMed ID: 23504257
[TBL] [Abstract][Full Text] [Related]
10. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
Zhang L; Liu F; Weygant N; Zhang J; Hu P; Qin Z; Yang J; Cheng Q; Fan F; Zeng Y; Tang Y; Li Y; Tang A; He F; Peng J; Liao W; Hu Z; Li M; Liu Z
Cancer Lett; 2021 Mar; 500():87-97. PubMed ID: 33309780
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
Vizcaíno MA; Shah S; Eberhart CG; Rodriguez FJ
Hum Pathol; 2015 Sep; 46(9):1323-30. PubMed ID: 26190195
[TBL] [Abstract][Full Text] [Related]
12. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
13. Generating Patient-Derived Gliomas within Cerebral Organoids.
Linkous A; Fine HA
STAR Protoc; 2020 Jun; 1(1):. PubMed ID: 33103125
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion.
da Silva B; Mathew RK; Polson ES; Williams J; Wurdak H
SLAS Discov; 2018 Sep; 23(8):862-868. PubMed ID: 29543559
[TBL] [Abstract][Full Text] [Related]
15. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
[TBL] [Abstract][Full Text] [Related]
16. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models.
Suarez-Meade P; Watanabe F; Ruiz-Garcia H; Rafferty SB; Moniz-Garcia D; Schiapparelli PV; Jentoft ME; Imitola J; Quinones-Hinojosa A
J Neurooncol; 2023 Jan; 161(1):67-76. PubMed ID: 36595192
[TBL] [Abstract][Full Text] [Related]
18. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.
Krieger TG; Tirier SM; Park J; Jechow K; Eisemann T; Peterziel H; Angel P; Eils R; Conrad C
Neuro Oncol; 2020 Aug; 22(8):1138-1149. PubMed ID: 32297954
[TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.
Sonabend AM; Carminucci AS; Amendolara B; Bansal M; Leung R; Lei L; Realubit R; Li H; Karan C; Yun J; Showers C; Rothcock R; O J; Califano A; Canoll P; Bruce JN
Neuro Oncol; 2014 Sep; 16(9):1210-9. PubMed ID: 24637229
[TBL] [Abstract][Full Text] [Related]
20. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
